Alcista
$38.54
Precio del escenario
$38.480
-0.038 (-0.10%)Al cierre
Cinemark Holdings, Inc. is an operator in the theatrical exhibition industry. The Company operates theaters in the United States, Brazil, Argentina, Chile, Colombia, Peru, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, and Paraguay. Its segments include U.S. markets and international markets. It operates in approximately 500 theaters with 5,500 screens in 42 states domestically and 13 countries throughout South and Central America. It plays mainstream films from many different genres, such as animated films, family films, dramas, comedies, horror and action films. It offers content in both 2-D and 3-D formats in all of its theaters, and in many locations, it offers either its own premium large format, XD, IMAX or ScreenX. It offers a variety of alternative entertainment content for its guests, such as foreign, independent and faith-based films, as well as concert events and other special events in its theaters.
Cinemark Holdings Inc (CNK) is a good buy right now due to its current price of $38.48, which is below the average analyst price target of $40. Additionally, the company has shown strong financial recovery with a year-to-date change of +63.54% and a gross margin of 58.99% in Q2 2026, indicating solid profitability. However, a risk to consider is the insider selling, which has increased by 2039.74% over the last month, suggesting potential concerns about future performance.
Morgan Stanley
$40
2026-09-24
Morgan Stanley
2026-09-24
Precio objetivo
$40
Morgan Stanley
$42
2026-07-31
Morgan Stanley
2026-07-31
Precio objetivo
$42
B. Riley
$37
2026-07-31
B. Riley
2026-07-31
Precio objetivo
$37
Benchmark
$40
2026-07-31
Benchmark
2026-07-31
Precio objetivo
$40
Wedbush
$43
2026-07-31
Wedbush
2026-07-31
Precio objetivo
$43
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

AMC Entertainment Shares Surge 86% in 2026, Signaling a Turnaround

Cinemark Expands SCREENX Theaters by 20 Locations

Cinemark Expands SCREENX Theaters by 20 Locations

Paramount's Film Release Commitment Post-Warner Merger

NCM Acquires Captivate to Expand Advertising Platform
Cinemark Holdings, Inc. is an operator in the theatrical exhibition industry. The Company operates theaters in the United States, Brazil, Argentina, Chile, Colombia, Peru, Honduras, El Salvador, Nicaragua, Costa Rica, Panama, Guatemala, Bolivia, and Paraguay. Its segments include U.S. markets and international markets. It operates in approximately 500 theaters with 5,500 screens in 42 states domestically and 13 countries throughout South and Central America. It plays mainstream films from many different genres, such as animated films, family films, dramas, comedies, horror and action films. It offers content in both 2-D and 3-D formats in all of its theaters, and in many locations, it offers either its own premium large format, XD, IMAX or ScreenX. It offers a variety of alternative entertainment content for its guests, such as foreign, independent and faith-based films, as well as concert events and other special events in its theaters. It operates in the Consumer Cyclicals sector (SERVICES-MOTION PICTURE THEATERS industry).
Cinemark Holdings Inc (CNK) is a good buy right now due to its current price of $38.48, which is below the average analyst price target of $40. Additionally, the company has shown strong financial recovery with a year-to-date change of +63.54% and a gross margin of 58.99% in Q2 2026, indicating solid profitability. However, a risk to consider is the insider selling, which has increased by 2039.74% over the last month, suggesting potential concerns about future performance.
14 analysts cover CNK: 9 rate it Buy, 4 Hold and 1 Sell. The average price target is 33.67.
Aún no hay publicaciones
Regístrate o inicia sesión para participarEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.